WHO resumes using hydroxychloroquine in COVID trial; discouraging study retracted due to doubts

After a weeklong assessment of security information, the World Well being Group introduced at this time that it’s ending a “pause” in the use of the antimalarial drug hydroxychloroquine in a global medical trial of potential therapies for COVID-19.

Replace for 12:30 p.m. PT June 4: We’ve up to date this report with the retraction from The Lancet.
Back to top button